At a glance
- Originator Bago
- Class Analgesics; Anti-inflammatories; Benzoic acids; Small molecules
- Mechanism of Action Prostaglandin synthase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Inflammation; Rheumatic disorders
Most Recent Events
- 26 Jan 1995 No-Development-Reported for Rheumatic disorders in Argentina (Unknown route)
- 04 Nov 1994 No-Development-Reported for Inflammation in Argentina (Unknown route)